Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1995 3
1996 2
1997 3
1998 1
1999 4
2000 1
2001 1
2005 2
2006 2
2008 3
2009 1
2010 1
2011 2
2012 1
2017 1
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals.
Faillaci F, Marzi L, Critelli R, Milosa F, Schepis F, Turola E, Andreani S, Vandelli G, Bernabucci V, Lei B, D'Ambrosio F, Bristot L, Cavalletto L, Chemello L, Sighinolfi P, Manni P, Maiorana A, Caporali C, Bianchini M, Marsico M, Turco L, de Maria N, Del Buono M, Todesca P, di Lena L, Romagnoli D, Magistri P, di Benedetto F, Bruno S, Taliani G, Giannelli G, Martinez-Chantar ML, Villa E. Faillaci F, et al. Among authors: cavalletto l. Hepatology. 2018 Sep;68(3):1010-1024. doi: 10.1002/hep.29911. Hepatology. 2018. PMID: 29604220 Free PMC article.
Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals.
Pascut D, Cavalletto L, Pratama MY, Bresolin S, Trentin L, Basso G, Bedogni G, Tiribelli C, Chemello L. Pascut D, et al. Among authors: cavalletto l. Cancers (Basel). 2019 Nov 11;11(11):1773. doi: 10.3390/cancers11111773. Cancers (Basel). 2019. PMID: 31717959 Free PMC article.
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
Romano A, Angeli P, Piovesan S, Noventa F, Anastassopoulos G, Chemello L, Cavalletto L, Gambato M, Russo FP, Burra P, Vincenzi V, Scotton PG, Panese S, Tempesta D, Bertin T, Carrara M, Carlotto A, Capra F, Carolo G, Scroccaro G, Alberti A. Romano A, et al. Among authors: cavalletto l. J Hepatol. 2018 Aug;69(2):345-352. doi: 10.1016/j.jhep.2018.03.009. Epub 2018 Mar 16. J Hepatol. 2018. PMID: 29551707
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
Kondili LA, Gaeta GB, Brunetto MR, Di Leo A, Iannone A, Santantonio TA, Giammario A, Raimondo G, Filomia R, Coppola C, Amoruso DC, Blanc P, Del Pin B, Chemello L, Cavalletto L, Morisco F, Donnarumma L, Rumi MG, Gasbarrini A, Siciliano M, Massari M, Corsini R, Coco B, Madonia S, Cannizzaro M, Zignego AL, Monti M, Russo FP, Zanetto A, Persico M, Masarone M, Villa E, Bernabucci V, Taliani G, Biliotti E, Chessa L, Pasetto MC, Andreone P, Margotti M, Brancaccio G, Ieluzzi D, Borgia G, Zappulo E, Calvaruso V, Petta S, Falzano L, Quaranta MG, Weimer LE, Rosato S, Vella S, Giannini EG. Kondili LA, et al. Among authors: cavalletto l. PLoS One. 2017 Oct 4;12(10):e0185728. doi: 10.1371/journal.pone.0185728. eCollection 2017. PLoS One. 2017. PMID: 28977040 Free PMC article.
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis.
Biasiolo A, Chemello L, Quarta S, Cavalletto L, Bortolotti F, Caberlotto C, Beneduce L, Bernardinello E, Tono N, Fassina G, Gatta A, Pontisso P. Biasiolo A, et al. Among authors: cavalletto l. J Viral Hepat. 2008 Apr;15(4):246-9. doi: 10.1111/j.1365-2893.2007.00935.x. Epub 2008 Jan 30. J Viral Hepat. 2008. PMID: 18248333
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis.
Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L. Floreani A, et al. Among authors: cavalletto l. Dig Liver Dis. 2011 Nov;43(11):887-92. doi: 10.1016/j.dld.2011.06.011. Epub 2011 Jul 23. Dig Liver Dis. 2011. PMID: 21783442
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease.
Turato C, Ruvoletto MG, Biasiolo A, Quarta S, Tono N, Bernardinello E, Beneduce L, Fassina G, Cavalletto L, Chemello L, Merkel C, Gatta A, Pontisso P. Turato C, et al. Among authors: cavalletto l. Dig Liver Dis. 2009 Mar;41(3):212-6. doi: 10.1016/j.dld.2008.06.001. Epub 2008 Jul 25. Dig Liver Dis. 2009. PMID: 18657489
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.
Vidalino L, Doria A, Quarta SM, Crescenzi M, Ruvoletto M, Frezzato F, Trentin L, Turato C, Parolin MC, Ghirardello A, Iaccarino L, Cavalletto L, Chemello L, Gatta A, Pontisso P. Vidalino L, et al. Among authors: cavalletto l. Exp Biol Med (Maywood). 2012 Jul;237(7):793-802. doi: 10.1258/ebm.2012.012024. Epub 2012 Jul 24. Exp Biol Med (Maywood). 2012. PMID: 22829702
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S, Cavalletto L, Chemello L, Bernardinello E, Ragazzi E, Costa CV, Bertazzo A. Comai S, et al. Among authors: cavalletto l. Pharmacol Res. 2011 Jan;63(1):85-92. doi: 10.1016/j.phrs.2010.10.009. Epub 2010 Oct 19. Pharmacol Res. 2011. PMID: 20940053
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
Amodio P, De Toni EN, Cavalletto L, Mapelli D, Bernardinello E, Del Piccolo F, Bergamelli C, Costanzo R, Bergamaschi F, Poma SZ, Chemello L, Gatta A, Perini G. Amodio P, et al. Among authors: cavalletto l. J Affect Disord. 2005 Jan;84(1):93-8. doi: 10.1016/j.jad.2004.09.004. J Affect Disord. 2005. PMID: 15620390
33 results
Jump to page
Feedback